Loredana Ungureanu

Dr. Loredana Ungureanu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2014 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
Sorina DanescuSorina Danescu
Sorina Danescu
CHCristina Has
Cristina Has
SSS. Senila
S. Senila
LULoredana Ungureanu
Loredana Ungureanu
RCRaluca Cosgarea
Raluca Cosgarea

15 February 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
AVAlina Vasilovici
Alina Vasilovici
LULoredana Ungureanu
Loredana Ungureanu
LGLavinia Grigore
Lavinia Grigore
ECElena Cojocaru
Elena Cojocaru
SŞSimona Şenilă
Simona Şenilă
Actinic cheilitis or solar cheilosis is considered a precursor of malignancy or even an in situ squamous cell carcinoma (SCC) of the lip, located most frequently on the lower lip. Actinic cheilitis (AC) has a higher likelihood of developing into invasive SCC of the lip, which is one of the deadliest non-melanoma skin cancers. Risk factors include chronic UV exposure, increasing age, male gender, fair phototypes, chronic scarring, immunosuppressive therapy, and tobacco use. From a clinical point of view, AC is characterized by dryness, scaling, atrophy, indistinct borders, and erosions. Ulceration and the appearance of a nodule often suggest the progression to invasive SCC. Dermoscopic examination reveals white structureless areas, scales, erosions, and white halos of the vermilion. Reflectance confocal microscopy shows disruption of the stratum corneum, parakeratosis, an atypical honeycomb pattern, solar elastosis, and dilated and tortuous blood vessels with increased blood flow. The rate of malignant transformation ranges from 10 to 30% and early diagnoses and treatment are essential in preventing the development of invasive SCC. Optimal treatment has not been established yet, but invasive and topical treatments can be tried. The present paper aims to review the existing data regarding epidemiology, risk factors, clinical picture, non-invasive imaging, diagnosis, and therapy in AC.

20 August 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
LULoredana Ungureanu
Loredana Ungureanu
ICIoana Cosgarea
Ioana Cosgarea
SŞSimona Şenilǎ
Simona Şenilǎ
AVAlina Vasilovici
Alina Vasilovici
Basal cell carcinoma is one of the most common cancers in white people, with a continuous increase worldwide. Dermoscopy, a non-invasive technique, allows early diagnosis based on the presence of typical vascular structures, pigmented structures, and ulceration and the absence of specific melanocytic structures. Moreover, dermoscopy is useful in basal cell carcinoma management, enabling the differentiation between multiple histological subtypes, between pigmented and non-pigmented variants and allowing a more accurate assessment of surgical margins. After non-ablative therapies, dermoscopy allows the accurate detection of residual disease. The purpose of this review is to highlight the dermoscopic features encountered in basal cell carcinoma and to outline the role of dermoscopy for diagnosis and therapeutic response in this cancer.

LULoredana Ungureanu
Loredana Ungureanu
AAAdina Patricia Apostu
Adina Patricia Apostu
Stefan Cristian VesaStefan Cristian Vesa
Stefan Cristian Vesa
ACAlexandra Elena Cășeriu
Alexandra Elena Cășeriu
SFSimona Fratila
Simona Fratila
AVAlina Florentina Vasilovici
Alina Florentina Vasilovici
The COVID-19 pandemic affected the healthcare system in our country and led non-COVID patients to postpone medical visits that were not urgent. The purpose of this study was to investigate the impact of the first year of the COVID-19 pandemic on the trends in melanoma diagnosis and to compare the pathological characteristics of melanoma patients before and during the pandemic. The number of primary cutaneous melanomas diagnosed each month between 1 March 2019 and 29 February 2020 (pre-COVID-19) and between 1 March 2020 and 28 February 2021 (COVID-19) in the North-Western Region of Romania (Cluj and Bihor counties) was determined. The pathological characteristics of melanomas diagnosed in the two intervals were compared. The number of melanoma diagnoses substantially decreased during the pandemic, with 66 (−19.3%) fewer cutaneous melanomas being diagnosed in the first year of the pandemic when compared with the previous year. The tumor thickness and mitotic rate were significantly higher in cases found during the COVID-19 pandemic. Our study suggests that COVID-19 has delayed diagnosis in patients with melanoma, leading to the detection of thicker melanomas that may increase morbidity and mortality. Further studies are needed to determine the consequences of this delay on outcomes.

18 July 2023 in Life
Verified
Journal Article
Open access
PDF file
Gabriela IancuGabriela Iancu
Gabriela Iancu
Gabriela IancuGabriela Iancu
Gabriela Iancu
LULoredana Ungureanu
Loredana Ungureanu
SŞSimona C. Şenilǎ
Simona C. Şenilǎ
AHAdrian Gheorghe Hasegan
Adrian Gheorghe Hasegan
MRMaria Rotaru
Maria Rotaru
Telogen effluvium post-COVID-19 is a condition characterized by the diffuse and reversible loss of scalp hair in the period following infection with SARS-CoV-2, and it is currently the second cause of alopecia in women. In the context of the COVID-19 infection, intense psychological stress contributes to alopecia appearance, along with systemic inflammation, autoimmune reactions, oxidative stress, and virally induced hypoxia. Cytokines with proinflammatory action and vasoactive substances negatively modulate the metabolism of some molecules, such as proteoglycans, involved in the hair follicle’s growth cycle. Studies show that a large percentage of hairs will suddenly enter the catagen phase during a moderate to severe COVID-19 infection. In the present paper, we update the data from the literature with a clinical example. Our case highlighted that the telogen effluvium after infections with SARS-CoV-2 is reversible with appropriate dermatological treatment. For therapeutic success, informing the patient about this pathology’s self-limited and reversible character is essential to reduce the emotional stress that may aggravate the disease.

1 June 2016 in Medical Ultrasonography
Verified
Journal Article
Closed access
LULoredana Ungureanu
Loredana Ungureanu
CJCarolina Botar Jid
Carolina Botar Jid
ECElisabeta Candrea
Elisabeta Candrea
RCRodica Cosgarea
Rodica Cosgarea
SȘSimona Corina Șenilă
Simona Corina Șenilă
Melanoma is an aggressive tumour, resistant to treatment, derived from melanocytes, with an increasing incidence in the last years in the majority of countries. The most important prognostic factor in the initial stages (I/II) is the presence of metastases at the level of lymph nodes. Ultrasound (US) is a non-invasive method, used in the pre- and post-operative node evaluation due to its high availability, the reduced cost and easy reproducibility. TheUSaccuracy is however dependent on operator expertise. The present article proposes a presentation of the US role in the evaluation of lymph nodes in melanoma patients.